The samples of this cohort were segregated into the following groups: IDH-wild-type (WT) gliomas, IDH-mutant + 1p/19q non-codel gliomas, and IDH-mutant + 1p/19q codel gliomas. Here, IDH2 is linked to central nervous system cancer.